11-64591814-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_144585.4(SLC22A12):​c.258C>T​(p.His86His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.646 in 1,611,802 control chromosomes in the GnomAD database, including 353,155 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 23458 hom., cov: 32)
Exomes 𝑓: 0.66 ( 329697 hom. )

Consequence

SLC22A12
NM_144585.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0810

Publications

38 publications found
Variant links:
Genes affected
SLC22A12 (HGNC:17989): (solute carrier family 22 member 12) The protein encoded by this gene is a member of the organic anion transporter (OAT) family, and it acts as a urate transporter to regulate urate levels in blood. This protein is an integral membrane protein primarily found in epithelial cells of the proximal tubule of the kidney. An elevated level of serum urate, hyperuricemia, is associated with increased incidences of gout, and mutations in this gene cause renal hypouricemia type 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
SLC22A12 Gene-Disease associations (from GenCC):
  • hypouricemia, renal 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary renal hypouricemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-64591814-C-T is Benign according to our data. Variant chr11-64591814-C-T is described in ClinVar as Benign. ClinVar VariationId is 305230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.081 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.689 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A12NM_144585.4 linkc.258C>T p.His86His synonymous_variant Exon 1 of 10 ENST00000377574.6 NP_653186.2 Q96S37-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A12ENST00000377574.6 linkc.258C>T p.His86His synonymous_variant Exon 1 of 10 1 NM_144585.4 ENSP00000366797.1 Q96S37-1

Frequencies

GnomAD3 genomes
AF:
0.511
AC:
77661
AN:
151992
Hom.:
23461
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.834
Gnomad AMR
AF:
0.505
Gnomad ASJ
AF:
0.715
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.573
Gnomad FIN
AF:
0.572
Gnomad MID
AF:
0.633
Gnomad NFE
AF:
0.695
Gnomad OTH
AF:
0.554
GnomAD2 exomes
AF:
0.574
AC:
142203
AN:
247646
AF XY:
0.591
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.448
Gnomad ASJ exome
AF:
0.711
Gnomad EAS exome
AF:
0.225
Gnomad FIN exome
AF:
0.585
Gnomad NFE exome
AF:
0.701
Gnomad OTH exome
AF:
0.621
GnomAD4 exome
AF:
0.660
AC:
963709
AN:
1459692
Hom.:
329697
Cov.:
116
AF XY:
0.661
AC XY:
480096
AN XY:
726256
show subpopulations
African (AFR)
AF:
0.182
AC:
6100
AN:
33474
American (AMR)
AF:
0.452
AC:
20201
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.709
AC:
18520
AN:
26122
East Asian (EAS)
AF:
0.202
AC:
8037
AN:
39690
South Asian (SAS)
AF:
0.593
AC:
51182
AN:
86250
European-Finnish (FIN)
AF:
0.593
AC:
30492
AN:
51418
Middle Eastern (MID)
AF:
0.653
AC:
3749
AN:
5742
European-Non Finnish (NFE)
AF:
0.708
AC:
787633
AN:
1111928
Other (OTH)
AF:
0.626
AC:
37795
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
24394
48789
73183
97578
121972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19466
38932
58398
77864
97330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.511
AC:
77676
AN:
152110
Hom.:
23458
Cov.:
32
AF XY:
0.505
AC XY:
37516
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.198
AC:
8210
AN:
41500
American (AMR)
AF:
0.505
AC:
7717
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.715
AC:
2481
AN:
3472
East Asian (EAS)
AF:
0.220
AC:
1136
AN:
5164
South Asian (SAS)
AF:
0.573
AC:
2764
AN:
4822
European-Finnish (FIN)
AF:
0.572
AC:
6048
AN:
10582
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.695
AC:
47200
AN:
67962
Other (OTH)
AF:
0.555
AC:
1173
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1607
3214
4820
6427
8034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.526
Hom.:
7702
Bravo
AF:
0.492
Asia WGS
AF:
0.382
AC:
1329
AN:
3478
EpiCase
AF:
0.708
EpiControl
AF:
0.705

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 16385546) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dalmatian hypouricemia Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.His86His in exon 1 of SLC22A12: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 69.98% (45710/6532 0) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exa c.broadinstitute.org; dbSNP rs3825016). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
3.0
DANN
Benign
0.50
PhyloP100
0.081
Mutation Taster
=287/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3825016; hg19: chr11-64359286; COSMIC: COSV60570777; API